Skip to Content Facebook Feature Image

OMOWAY Brings Its Smart Mobility 3.0 Concept to Web Summit 2026

Business

OMOWAY Brings Its Smart Mobility 3.0 Concept to Web Summit 2026
Business

Business

OMOWAY Brings Its Smart Mobility 3.0 Concept to Web Summit 2026

2026-11-16 17:43 Last Updated At:18:05

SINGAPORE, Nov. 16, 2026 /PRNewswire/ -- OMOWAY, a global technology company focused on intelligent mobility and robotics, participated in Web Summit 2026, one of the world's leading technology conferences, held in Lisbon, Portugal. On November 12, OMOWAY Chief Product Officer Nick Yu joined a panel discussion alongside leaders from across the technology industry, sharing the company's perspectives on innovation and opportunities for global expansion.

During the discussion, Yu highlighted how OMOWAY is integrating robotics with intelligent sensing and control technologies from the automotive industry to create new possibilities for wheeled mobility.

"One example is our proprietary Balance Support technology," said Yu, "which provides riders with balance assistance in specific low-speed situations."

This feature is powered by OMOWAY's OMO-Robot Universal Architecture, first implemented in the company's debut product, OMO-X. As the world's first mass-produced self-balancing electric motorcycle, OMO-X translates these breakthroughs into enhanced stability and riding assistance for two-wheeled mobility.

Building on this unified foundation, OMOWAY is extending these core capabilities beyond smart motorcycles into broader platforms, such as wheeled robots. This strategic move reflects the company's ambition to diversify its product portfolio and scale its innovations into new categories.

At the core of this expansion is OMOWAY's concept of Smart Mobility 3.0: smart technology should go beyond simply adding features to a product. Instead, it should be deeply integrated into product design and user experience, creating value across a wider range of mobility scenarios. Ultimately, OMOWAY aims to make everyday movement more intuitive, accessible and enjoyable.

Speaking about the company's global outlook, Yu said, "OMOWAY has been global in its vision from day one. We believe innovation should not be limited by geography. By bringing together talent, technology and expertise from different markets, we aim to create products that deliver meaningful value to users worldwide."

Today, Guangzhou serves as OMOWAY's R&D base, while Singapore is its brand center. The company is also developing local operations in key markets such as Indonesia and Thailand.

Through its participation in Web Summit 2026, OMOWAY is accelerating its global expansion and connecting with industry leaders worldwide. Looking ahead, the company will continue to advance Smart Mobility 3.0, extending its innovations across diverse applications to contribute to smarter, more sustainable ways of living globally.

About OMOWAY

OMOWAY is a global technology company specializing in intelligent vision algorithms, mechanical innovation, and integrated hardware and software technologies. These technologies are applied across smart motorcycles and wheeled robots, exploring new possibilities for smart mobility. Guided by its mission to deliver innovative smart experiences to users worldwide, OMOWAY is committed to driving intelligence and sustainability globally.

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

OMOWAY Brings Its Smart Mobility 3.0 Concept to Web Summit 2026

OMOWAY Brings Its Smart Mobility 3.0 Concept to Web Summit 2026

DÜSSELDORF, Germany, Nov. 16, 2026 /PRNewswire/ -- When a complete blood count (CBC) flags an unusual finding, seeing the cells can provide valuable context for further review. At MEDICA 2026, Ozelle is demonstrating O-Cyte 1, an automated hematology analyzer that brings high-resolution cell imaging into routine CBC testing.

Ozelle's AI × CBM (Complete Blood Morphology) technology combines cell imaging with AI-assisted morphology analysis. O-Cyte 1 integrates this capability with 7-part white blood cell differentiation. Cell images captured during automated testing are available with CBC results for laboratory professionals to review when further morphology assessment is needed.

In busy laboratories, the added information must fit into the existing testing workflow. O-Cyte 1 supports 25-tube batch loading, automated barcode identification and mixing, closed-tube sampling and STAT priority. A standalone analyzer processes up to 60 tests per hour, while six connected units reach up to 360 tests per hour, allowing laboratories to expand capacity as workloads grow.

Routine maintenance is another practical concern. Conventional analyzers with reusable internal fluid paths require regular cleaning. O-Cyte 1 instead integrates key fluid-contact components into a replaceable reagent kit, helping reduce cleaning inside the instrument. Built-in self-checks and replaceable modules support easier troubleshooting and servicing, including after-sales support for distributors.

"We wanted to make cell morphology part of routine CBC testing while keeping laboratory workflows efficient," said Jie Du, Co-founder and Head of R&D at Ozelle. "That meant designing the entire system with sample handling, image review and maintenance in mind."

For clinics and decentralized testing sites, the priority is broader testing within limited space and with less upkeep. Ozelle's compact EHBT analyzer series for human care covers hematology, cell imaging, immunoassay and dry biochemistry. Its EHVT veterinary series offers hematology, digital cell morphology, immunoassay, biochemistry, urine and fecal testing. Both product lines emphasize reliable performance, straightforward operation and minimal routine maintenance.

Live demonstrations continue through November 19 at Hall 1, Booth D63, Messe Düsseldorf. Visitors can see the analyzers at work and discuss clinical applications and distribution opportunities. To arrange a meeting or product demonstration, contact the Ozelle team.

Learn More About Ozelle

www.ozellemed.com
info@ozellepoct.com

 

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

From CBC Results to Cell Images: Ozelle Demonstrates O-Cyte 1 at MEDICA 2026

From CBC Results to Cell Images: Ozelle Demonstrates O-Cyte 1 at MEDICA 2026

Recommended Articles